Prevalence of tubulopathy and association with renal function loss in HIV-infected patients. Issue 4 (9th May 2019)

• Record Type: Journal Article
• Authors: Lescure, François-Xavier; Fellahi, Soraya; Pialoux, Gilles; Bastard, Jean-Philippe; Eme, Anne-Line; Esteve, Emmanuel; Lebrette, Marie-Gisèle; Guiard-Schmid, Jean-Baptiste; Capeau, Jacqueline; Ronco, Pierre; Costagliola, Dominique; Plaisier, Emmanuelle
• Is Part Of: Nephrology dialysis transplantation. Volume 35:Issue 4(2020)
• Page Start: 607
• Page End: 615
• Publication Date: 2019-05-09
• Subjects: ethnicity -- GFR -- HIV -- microalbuminuria -- proximal tubule dysfunction; Nephrology -- Periodicals; Hemodialysis -- Periodicals; Kidneys -- Transplantation -- Periodicals; Hemodialysis; Kidneys -- Transplantation; Nephrology; Periodicals; 616.61
• DOI: 10.1093/ndt/gfz081
• Languages: English
• ISSNs: 0931-0509

Abstract

Abstract: Background: The incidence of chronic kidney disease (CKD) is 10 times higher in human immunodeficiency virus (HIV)-infected patients than in the general population. We explored the prevalence and determinants of proximal tubular dysfunction (PTD) in HIV-infected individuals, and assessed the impact of the tubulopathy on the estimated glomerular filtration rate (eGFR) outcome. Methods: A cohort study was performed on 694 outpatients followed in a French centre to analyse the prevalence of PTD, the diagnosis performance of screening tools and the associated factors. eGFR was prospectively evaluated to analyse the predictive value of the tubulopathy on eGFR decrease. Results: At inclusion, 14% of the patients presented with PTD and 5% with CKD. No individual tubular marker, including non-glomerular proteinuria, glycosuria dipstick or hypophosphataemia, registered sufficient performance to identify PTD. We found a significant interaction between tenofovir disoproxil fumarate exposure and ethnicity (P = 0.03) for tubulopathy risk. Tenofovir disoproxil fumarate exposure was associated with PTD in non-Africans [adjusted odds ratio (aOR) = 4.71, P < 10 −3 ], but not in patients of sub-Saharan African origin (aOR = 1.17, P = 0.73). Among the 601 patients followed during a median of 4.3 years, 13% experienced an accelerated eGFR decline. Unlike microalbuminuria and glomerular proteinuria, tubulopathy was not associated with accelerated eGFR decline. Conclusion: PTD is not rare in HIV-infected individuals but is less frequent in sub-Saharan African patients and is associated with tenofovir disoproxil fumarate exposure only in non-Africans. Its diagnosis requires multiple biochemical testing and it is not associated with an accelerated eGFR decline.